Comparison Orchestra BioMed (OBIO) with Competitors
Orchestra BioMed (OBIO) industry is Biotechnology.
Profit Margin
OBIO-167.00%
Industry-0.77%
Upside-166.23%
Operating Margin
OBIO-20069.00%
Industry-2055.25%
Upside-18013.75%
Debt-to-Equity
OBIO36.41%
Industry28.27%
Upside+28.82%
Free Cash Flow Yield
OBIO-25.74%
Industry-1.75%
Upside-23.99%
P/E
OBIO-3.28
Industry-20.52
Upside+1723.89%
P/S
OBIO6.68
Industry10.01
Upside-33.29%
P/B
OBIO5.37
Industry5.15
Upside+4.34%